Researchers from Newcastle University are investigating the genetic causes of male infertility — an often-overlooked condition about which very little is known.
When it comes to cancer treatment, tumour mutational burden has become increasingly utilised as a biomarker for immunotherapy response prediction.
The four new genes contribute to the devastating neurological disease, multiple sclerosis (MS).
The UK's 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes, just over five years after it was announced by then Prime Minister David Cameron.
GeneCopoeia's Genome-CRISP CRISPR-Cas9 products and services are designed to provide a complete, powerful solution for precision RNA-guided genome editing.
GeneCopoeia's AAVPrime adeno-associated virus (AAV) products are useful tools for inserting genes into a broad range of cell types with high efficiency and enhanced safety.
Lunatic from Unchained Labs makes batch quantification of protein, DNA and RNA simple. It is said to be the easiest-to-use system on the market that can batch measure biologics and genomics from low to high concentrations due to its dynamic range of 0.03–200 OD.
A good beer is all about the yeast, but can next-generation sequencing lead to a better brew?
Illumina has announced the Nextera DNA Flex Library Prep Kit for whole genome sequencing. It eliminates the need for sample preparation for whole blood and saliva and removes tedious steps in the library prep workflow, such as mechanical fragmentation of DNA, quantification and normalisation.
The latest research by a team from Cornell University has found that current approaches to gene drives may need to be rethought.
The world of genomics just got a whole lot richer, with scientists completing sequencing for not one but two crop genomes over the past week.
US researchers have addressed a longstanding question about how DNA functions are organised in space and time, including how genes are regulated to be silenced or expressed.
A major release of reference genomes is expected to pave the way for future health, biotechnology and agricultural products.
The city of Brisbane has become home to what is claimed to be the world's most advanced genomics sequencer.
Science and technology company Merck has developed a new genome editing tool that is said to make CRISPR more efficient, flexible and specific.